Clinical trial
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin…
NCT00236327 · Janssen Cilag S.A.S., Industry · Terminated
Key facts
| NCT number | NCT00236327 |
|---|---|
| Title | Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain |
| Official title | Evaluation of the Efficacy and Safety of Transdermal Fentanyl in Patients Suffering From Chronic Cancer Pain in an Ambulatory Setting |
| Lead sponsor | Janssen Cilag S.A.S., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | fentanyl |
| Enrollment | 34 |
| Start date | Jun 1, 2003 |
| Completion | May 1, 2004 |
| First posted | Oct 12, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: